Please enable JavaScript to continue using this application.

Compare $ARMP vs $KRRO | Chartloom

Compare

$ARMP vs $KRRO

Armata Pharmaceuticals Inc · Korro Bio Inc

ARMP

Armata Pharmaceuticals Inc

KRRO

Korro Bio Inc

Compare $ARMP vs $KRRO

Comparing Armata Pharmaceuticals Inc and Korro Bio Inc

ARMPArmata Pharmaceuticals Inc

KRROKorro Bio Inc

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

KRRO

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

KRRO

Korro Bio Inc

Market Cap

ARMP$133M

KRRO$147M

Enterprise Value

ARMP$393M

KRRO$122M

Price

ARMP$3.63

KRRO$10.16

P/E Ratio

ARMPN/A

KRRON/A

P/S Ratio

ARMP24.04x

KRRO61.51x

EV/Sales

ARMP70.87x

KRRO51.05x

EV/EBITDA

ARMP0.00x

KRRO0.00x

P/B Ratio

ARMP6.85x

KRRO1.38x

P/FCF Ratio

ARMPN/A

KRRON/A

EV/FCF

ARMP-15.23x

KRRO-1.78x

PEG Ratio

ARMPN/A

KRRON/A

Forward P/E (NTM)

ARMPN/A

KRRON/A

Forward P/S (NTM)

ARMPN/A

KRRO143.63x

Revenue (TTM)

ARMP$6M

KRRO$2M

Revenue Growth (YoY)

ARMP-19.3%

KRRO-62.1%

Forward Rev Growth

ARMP-35.3%

KRRO240.0%

Gross Margin (TTM)

ARMP0.0%

KRRO0.0%

Operating Margin (TTM)

ARMP0.0%

KRRO0.0%

EBITDA Margin (TTM)

ARMP-603.4%

KRRO-3068.6%

Net Margin (TTM)

ARMP-3467.0%

KRRO-4477.1%

FCF Margin (TTM)

ARMP-465.3%

KRRO-2865.9%

Net Income (TTM)

ARMP$-192M

KRRO$-107M

FCF (TTM)

ARMP$-26M

KRRO$-68M

EPS (TTM)

ARMP-$3.10

KRRO-$6.05

ROE (TTM)

ARMP-12000.0%

KRRO-11426.0%

ROA (TTM)

ARMP-23569.0%

KRRO-6857.0%

ROIC (TTM)

ARMP-8123.0%

KRRO-11426.0%

Cash

ARMP$24M

KRRO$25M

Debt

ARMP$284M

KRRO$0

Net Cash/Debt

ARMP$-260M

KRRO$25M

Current Ratio (TTM)

ARMP0.11x

KRRO9.55x

Quick Ratio (TTM)

ARMP0.11x

KRRO9.11x

Debt/Equity (TTM)

ARMP1.38x

KRRO0.00x

Debt/Assets (TTM)

ARMP0.0%

KRRO0.0%

Interest Coverage (TTM)

ARMPN/A

KRRON/A

Net Debt/EBITDA (TTM)

ARMP0.00x

KRRO0.00x

Beta

ARMP1.66

KRRO3.27

52W Performance

ARMP12.7%

KRRO-77.8%

YTD Performance

ARMP-44.7%

KRRO26.2%

% from 52W High

ARMP-77.8%

KRRO-81.8%

% from 52W Low

ARMP17.5%

KRRO95.2%

Asset Turnover (TTM)

ARMP0.07x

KRRO0.04x

FCF Yield (TTM)

ARMP-19.4%

KRRO-46.6%

Earnings Yield (TTM)

ARMP-144.2%

KRRO-72.8%

Dividend Yield (TTM)

ARMPN/A

KRRON/A

Rule of 40

ARMP-484.6

KRRO-2,927.9

EV/GP/RG

ARMPN/A

KRRON/A

Ticker research

View ARMP research View KRRO research

Metric	ARMP Armata Pharmaceuticals Inc	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$133M	$147M
Enterprise Value	$393M	$122M
Price	$3.63	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	61.51x
EV/Sales	70.87x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$6M	$2M
Revenue Growth (YoY)	-19.3%	-62.1%
Forward Rev Growth	-35.3%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-3068.6%
Net Margin (TTM)	-3467.0%	-4477.1%
FCF Margin (TTM)	-465.3%	-2865.9%
Net Income (TTM)	$-192M	$-107M
FCF (TTM)	$-26M	$-68M
EPS (TTM)	-$3.10	-$6.05
ROE (TTM)	-12000.0%	-11426.0%
ROA (TTM)	-23569.0%	-6857.0%
ROIC (TTM)	-8123.0%	-11426.0%
Financial Health
Cash	$24M	$25M
Debt	$284M	$0
Net Cash/Debt	$-260M	$25M
Current Ratio (TTM)	0.11x	9.55x
Quick Ratio (TTM)	0.11x	9.11x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	3.27
52W Performance	12.7%	-77.8%
YTD Performance	-44.7%	26.2%
% from 52W High	-77.8%	-81.8%
% from 52W Low	17.5%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.04x
FCF Yield (TTM)	-19.4%	-46.6%
Earnings Yield (TTM)	-144.2%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View KRRO research

Valuation

P/S Ratio

ARMP

24.04x

KRRO

61.51x

EV/FCF

ARMP

-15.23x

KRRO

-1.78x

Growth & revenue

Revenue Growth TTM

ARMP

-19.3%

KRRO

-62.1%

Forward Revenue Growth

KRRO

240.0%

ARMP

-35.3%

Profitability & performance

Gross Margin

ARMP

0.0%

KRRO

0.0%

ROE

KRRO

-11426.0%

ARMP

-12000.0%

FCF Yield %

ARMP

-19.4%

KRRO

-46.6%

52-Week Performance

ARMP

12.7%

KRRO

-77.8%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

KRRO

Korro Bio Inc

Market Cap

ARMP$133M

KRRO$147M

Enterprise Value

ARMP$393M

KRRO$122M

Price

ARMP$3.63

KRRO$10.16

P/E Ratio

ARMPN/A

KRRON/A

P/S Ratio

ARMP24.04x

KRRO61.51x

EV/Sales

ARMP70.87x

KRRO51.05x

EV/EBITDA

ARMP0.00x

KRRO0.00x

P/B Ratio

ARMP6.85x

KRRO1.38x

P/FCF Ratio

ARMPN/A

KRRON/A

EV/FCF

ARMP-15.23x

KRRO-1.78x

PEG Ratio

ARMPN/A

KRRON/A

Forward P/E (NTM)

ARMPN/A

KRRON/A

Forward P/S (NTM)

ARMPN/A

KRRO143.63x

Revenue (TTM)

ARMP$6M

KRRO$2M

Revenue Growth (YoY)

ARMP-19.3%

KRRO-62.1%

Forward Rev Growth

ARMP-35.3%

KRRO240.0%

Gross Margin (TTM)

ARMP0.0%

KRRO0.0%

Operating Margin (TTM)

ARMP0.0%

KRRO0.0%

EBITDA Margin (TTM)

ARMP-603.4%

KRRO-3068.6%

Net Margin (TTM)

ARMP-3467.0%

KRRO-4477.1%

FCF Margin (TTM)

ARMP-465.3%

KRRO-2865.9%

Net Income (TTM)

ARMP$-192M

KRRO$-107M

FCF (TTM)

ARMP$-26M

KRRO$-68M

EPS (TTM)

ARMP-$3.10

KRRO-$6.05

ROE (TTM)

ARMP-12000.0%

KRRO-11426.0%

ROA (TTM)

ARMP-23569.0%

KRRO-6857.0%

ROIC (TTM)

ARMP-8123.0%

KRRO-11426.0%

Cash

ARMP$24M

KRRO$25M

Debt

ARMP$284M

KRRO$0

Net Cash/Debt

ARMP$-260M

KRRO$25M

Current Ratio (TTM)

ARMP0.11x

KRRO9.55x

Quick Ratio (TTM)

ARMP0.11x

KRRO9.11x

Debt/Equity (TTM)

ARMP1.38x

KRRO0.00x

Debt/Assets (TTM)

ARMP0.0%

KRRO0.0%

Interest Coverage (TTM)

ARMPN/A

KRRON/A

Net Debt/EBITDA (TTM)

ARMP0.00x

KRRO0.00x

Beta

ARMP1.66

KRRO3.27

52W Performance

ARMP12.7%

KRRO-77.8%

YTD Performance

ARMP-44.7%

KRRO26.2%

% from 52W High

ARMP-77.8%

KRRO-81.8%

% from 52W Low

ARMP17.5%

KRRO95.2%

Asset Turnover (TTM)

ARMP0.07x

KRRO0.04x

FCF Yield (TTM)

ARMP-19.4%

KRRO-46.6%

Earnings Yield (TTM)

ARMP-144.2%

KRRO-72.8%

Dividend Yield (TTM)

ARMPN/A

KRRON/A

Rule of 40

ARMP-484.6

KRRO-2,927.9

EV/GP/RG

ARMPN/A

KRRON/A

Ticker research

View ARMP research View KRRO research

Metric	ARMP Armata Pharmaceuticals Inc	KRRO Korro Bio Inc
Market & Valuation
Market Cap	$133M	$147M
Enterprise Value	$393M	$122M
Price	$3.63	$10.16
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	61.51x
EV/Sales	70.87x	51.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-1.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	143.63x
Revenue & Growth
Revenue (TTM)	$6M	$2M
Revenue Growth (YoY)	-19.3%	-62.1%
Forward Rev Growth	-35.3%	240.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-3068.6%
Net Margin (TTM)	-3467.0%	-4477.1%
FCF Margin (TTM)	-465.3%	-2865.9%
Net Income (TTM)	$-192M	$-107M
FCF (TTM)	$-26M	$-68M
EPS (TTM)	-$3.10	-$6.05
ROE (TTM)	-12000.0%	-11426.0%
ROA (TTM)	-23569.0%	-6857.0%
ROIC (TTM)	-8123.0%	-11426.0%
Financial Health
Cash	$24M	$25M
Debt	$284M	$0
Net Cash/Debt	$-260M	$25M
Current Ratio (TTM)	0.11x	9.55x
Quick Ratio (TTM)	0.11x	9.11x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	3.27
52W Performance	12.7%	-77.8%
YTD Performance	-44.7%	26.2%
% from 52W High	-77.8%	-81.8%
% from 52W Low	17.5%	95.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.04x
FCF Yield (TTM)	-19.4%	-46.6%
Earnings Yield (TTM)	-144.2%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-2,927.9
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View KRRO research